61875-53-4

Basic information

• Product Name: 2,6-Dichlorophenylacetic acid chloride
• Synonyms: 2,6-Dichlorophenylacetic acid chloride;2-(2,6-Dichlorophenyl)acetyl chloride;2-(2,6-Dichorophenyl)acetyl chloride
• CAS NO: 61875-53-4
• Molecular Formula: C₈H₅Cl₃O
• Molecular Weight: 223.49
• Mol File: 61875-53-4.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,6-Dichlorophenylacetic acid chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-Dichlorophenylacetic acid chloride(61875-53-4)
• EPA Substance Registry System: 2,6-Dichlorophenylacetic acid chloride(61875-53-4)

Safety Data

• Hazardous Substances Data: 61875-53-4(Hazardous Substances Data)

Usage

Molecular weight

191.03 g/mol

Chemical structure

A phenyl ring with two chlorine atoms attached to the 2 and 6 positions, and an acetyl chloride group attached to the phenyl ring.

Appearance

White to off-white crystalline solid.

Melting point

70-73°C

Boiling point

140-145°C (decomposes)

Solubility

Slightly soluble in water, soluble in organic solvents such as ethanol, ether, and chloroform.

Reactivity

Reacts with nucleophiles and bases, can undergo substitution reactions.

Uses

Building block in organic synthesis, used to create various compounds including pharmaceuticals and agrochemicals.

Handling precautions

Corrosive and harmful if it comes into contact with skin or eyes, should be handled in a controlled laboratory setting by trained professionals.

Upstream product

• 3215-64-3 2,6-dichlorophenylacetonitrile 
• 2014-83-7 1,3-Dichloro-2-chloromethyl-benzene 
• 6575-24-2 2-(2,6-dichlorophenyl)acetic acid 

Downstream Products

• 70925-95-0 3-amino-5-(2,6-dichlorobenzyl)-1,2,4-oxadiazole 
• 102871-55-6 1,3-dichloro-2-<(phenylthio)methyl>benzene 
• 78622-22-7 2-(2,6-dichlorophenyl)acetylurea 
• 221121-45-5 ethyl 4-(2,6-dichlorophenyl)-3-oxobutanoate 
• 5982-36-5 2-(2,6-dichlorophenyl)-N,N-diethylacetamide 
• 1448628-02-1 N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)-2-(2,6-dichlorobenzyl)oxazolo[5,4-d]pyrimidin-7-amine 
• 1448628-07-6 tert-butyl 5-((2-(2,6-dichlorobenzyl)oxazolo[5,4-d]pyrimidin-7-ylamino)methyl)-4,6-dimethylpyridin-2-ylcarbamate 
• 1160608-64-9 7-chloro-2-(2,6-dichlorobenzyl)oxazolo[5,4-d]pyrimidine 
• 87616-78-2 2-(2,6-dichlorophenyl)-1-hydroxyethylidenebisphosphonic acid 
• 1160606-90-5 JNJ-39729209 
• 1268267-61-3 C₁₉H₁₃Cl₂F₃N₄OS 
• 1160608-92-3 N-[4-chloro-6-(4-trifluoromethyl-phenylamino)-pyrimidin-5-yl]-2-(2,6-dichloro-phenyl)-acetamide 
• 1273911-80-0 2-(2,6-dichlorophenyl)-1-p-tolylethanone 
• 1186621-86-2 5-[(2,6-dichlorobenzyl)carbonyl]amino-8-isopentyl-2-(2-furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine 

Relevant articles and documents

N-arylacetyl thiosemicarbazide urease inhibitor and preparation method and application thereof

N-arylacetyl thiosemicarbazide compounds have a structural formula as shown in the specification, have great inhibiting effects on urease and can be used for preparation of medicines for treating gastritis, gastric ulcer, lithangiuria and the like. The in

Structural insight into the optimization of ethyl 5-hydroxybenzo[g]indol-3-carboxylates and their bioisosteric analogues as 5-LO/m-PGES-1 dual inhibitors able to suppress inflammation

The release of pro-inflammatory mediators, such as prostaglandines (PGs) and leukotrienes (LTs), arising from the arachidonic acid (AA) cascade, play a crucial role in initiating, maintaining, and regulating inflammatory processes. New dual inhibitors of 5-lipoxygenase (5-LO) and microsomal prostaglandin E2 synthase-1 (mPGES-1), that block, at the same time, the formation of PGE2 and LTs, are currently emerged as a highly interesting drug candidates for better pharmacotherapie of inflammation-related disorders. Following our previous studies, we here performed a detailed structure-based design of benzo[g]indol-3-carboxylate derivatives, disclosing several new key factors that affect both enzyme activity. Ethyl 2-(3,4-dichlorobenzyl)-5-hydroxy-1H-benzo[g]indole-3-carboxylate (4b, RAF-01) and ethyl 2-(3,4-dichlorophenyl)-5-hydroxy-1H-benzo[g]indole-3-carboxylate (7h, RAF-02) emerged as the most active compounds of the series. Additionally, together with selected structure based analogues, both derivatives displayed significant in vivo anti-inflammatory properties. In conclusion, modeling and experimental studies lead to the discovery of new candidate compounds prone to further developments as multi-target inhibitors of the inflammatory pathway.

Synthesis of Unsymmetrical Diaryl Acetamides, Benzofurans, Benzophenones, and Xanthenes by Transition-Metal-Free Oxidative Cross-Coupling of sp3 and sp2 C-H Bonds

A chemo- and regioselective intermolecular sp3 C-H and sp2 C-H coupling reaction for C-C bond formation is described to access unsymmetrical diaryl acetamides under TM-free conditions from sec- and tert-arylacetamides and nitroarenes using tert-butoxide base in DMSO at room temperature. The coupling partners with sensitive functionalities such as chloro, bromo, hydroxy, and cyano were also amenable to the developed reaction. Synthesized α-(2/4-nitroaryl) phenylacetamides have been transformed into biologically important benzofurans, xanthenes, diaryl indoles, and unsymmetrical benzophenones by novel routes without applying a transition metal. Overall, an economical, yet efficient, strategy has been devised to access unsymmetrical diarylacetamides with the possibility of their further elaboration into a variety of biologically important heterocycles. Mechanistic understanding suggests that the reaction proceeds by a nucleophilic addition of a phenylacetamide carbanion, which is generated in the presence of tert-butoxide base, to the para or ortho (if para is substituted) position of nitrobenzene. The formed α-(4-nitrocyclohexa-2,4-dien-1-yl) phenylacetamide anion intermediate oxidized by a basic solution of DMSO or atmospheric oxygen led to the desired sp3 C-H and sp2 C-H coupled α-(2/4-nitroaryl) phenylacetamides.

Synthesis and evaluation of effective inhibitors of plant δ1-pyrroline-5-carboxylate reductase

Analogues of previously studied phenyl-substituted aminomethylene- bisphosphonic acids were synthesized and evaluated as inhibitors of Arabidopsis thaliana δ1-pyrroline-5-carboxylate reductase. With the aim of improving their effectiveness, two main modifications were introduced into the inhibitory scaffold: the aminomethylenebisphosphonic moiety was replaced with a hydroxymethylenebisphosphonic group, and the length of the molecule was increased by replacing the methylene linker with an ethylidene chain. In addition, chlorine atoms in the phenyl ring were replaced with various other substituents. Most of the studied derivatives showed activity in the micromolar to millimolar range, with two of them being more effective than the lead compound, with concentrations inhibiting 50% of enzyme activity as low as 50 μM. Experimental evidence supporting the ability of these inhibitors to interfere with proline synthesis in vivo is also shown.

AMINOPYRIDINE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS

The invention relates to compound of the formula (I) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

Scale-up synthesis of a TRPV1 antagonist featuring a facile thiazolo[5,4-d]pyrimidine formation

An efficient and practical synthesis of a TRPV1 inhibitor bearing a thiazolo[5,4-d]pyrimidine core was developed. The initial synthesis was modified to facilitate acylation of 5-aminopyrimidine and subsequent thiazole formation. The synthesis features an efficient two-pot, five-step process for the construction of the thiazolo[5,4-d]pyrimidine ring. The new route is concise, chromatography-free, and amenable to large-scale preparation.

Synthesis of (2-chlorophenyl)(phenyl)methanones and 2-(2-chlorophenyl)-1- phenylethanones by Friedel-Crafts acylation of 2-chlorobenzoic acids and 2-(2-chlorophenyl)acetic acids using microwave heating

Several 2-(2-chlorophenyl)-1-phenylethanones and (2-chlorophenyl)(phenyl) methanones were prepared by the Friedel-Crafts acylation reaction of 2-(2-chlorophenyl) acetic acids and 2-chlorocarboxylic acids, respectively, in the presence of cyanuric chloride, pyridine, and AlCl3 or FeCl 3 using microwave heating. The yields of the ketones were significantly higher than those obtained using conventional heating. In addition, similar reactions carried out with the less inexpensive and less toxic FeCl3 gave titled ketones in comparable yields. Interestingly, the FeCl3 catalyzed reactions gave pure ketones (no chromatographic purification required), whereas the AlCl3 catalyzed reaction gave impure product that required chromatographic purification.

Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1

Certain TRPV1-modulating imidazolo-, oxazolo-, and thiazolopyrimdine compounds are described. The compounds may be used in pharmaceutical compositions and methods for treating disease states, disorders, and conditions mediated by TRPV1 activity, such as pain, arthritis, itch, cough, asthma, or inflammatory bowel disease.

NOVEL AZOLES AND RELATED DERIVATIVES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NNRTIS) IN ANTIVIRAL THERAPY (HIV)

The present invention relates to novel heterocyclic compounds, including oxadiazole compounds, pharmaceutical compositions and their use in the inhibition of reverse transcriptase and the treatment of HIV (1 and 2) infections, AIDS and ARC and other viral

Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same

Compounds of Formula 1 where the variables have the meaning defined in the specification are used to activate alpha2 adrenergic receptors. The compounds of Formula 1 are incorporated in pharmaceutical compositions and are used as medicaments in mammals, including humans, for treatment of diseases and or alleviations of conditions which are responsive to treatment by agonists of alpha2 adrenergic receptors.